Comparison of Incidence of Bleeding and Mortality of Men Versus Women With ST-Elevation Myocardial Infarction Treated With Fibrinolysis - 17/01/12
, Amanda S. Stebbins, MS a, Renato D. Lopes, MD, PhD a, Robert M. Califf, MD a, Karen S. Pieper, MS a, Paul W. Armstrong, MD b, Frans Van de Werf, MD, PhD c, Judith S. Hochman, MD d, Harvey D. White, MD, DSc e, Eric J. Topol, MD f, John H. Alexander, MD, MS a, Christopher B. Granger, MD a
Corresponding author: Tel: 919-668-8971; fax: 919-668-7056Résumé |
Gender-related differences in the incidence of bleeding and its relation to subsequent mortality in patients with ST-segment elevation myocardial infarction (STEMI) treated with fibrinolysis are not well understood. We studied patients with STEMI receiving fibrinolysis enrolled in 6 clinical trials. Outcomes included moderate or severe bleeding defined using Global Utilization of Strategies to Open Occluded Arteries (GUSTO) criteria and adjusted 1-year mortality (excluding deaths in first 24 hours). Moderate or severe bleeding was 1.9-fold higher in women compared to men (13.3% vs 7.1%, p <0.0001). Bleeding remained higher in women even after adjustment for baseline differences (odd ratios 1.52, 95% confidence interval [CI] 1.42 to 1.62). In fact, female gender was second most important prognostic factor (Wald chi-square 153.6) after older age (Wald chi-square 241.2) in the multivariable bleeding model. Overall 1-year mortality was similar in women and men after adjusting for prognostically important baseline differences (hazard ratio [HR] 1.06, 95% CI 0.97 to 1.17). However, after adjustment for baseline confounders and bleeding, female gender was associated with a lower risk of 1-year death. Thus, adjusted 1-year mortality was similar in women compared to men without bleeding (HR 1.08, 95% CI 0.97 to 1.19) but lower in women compared to men with bleeding (HR 0.85, 95% CI 0.73 to 0.98, p for interaction of gender by bleeding = 0.0016). The highest adjusted 1-year mortality was observed in men with bleeding (HR 2.42, 95% CI 2.20 to 2.66) followed by women with bleeding (HR 2.05, 95% CI 1.80 to 2.33) and women without bleeding (HR 1.08, 95% CI 0.97 to 1.19, referent men without bleeding). In conclusion, in patients with fibrinolytic-treated STEMI, women had a higher incidence but lower mortality with bleeding than men. These data highlight the importance of understanding factors associated with gender-related differences in bleeding and represent an opportunity for improving outcomes of women and men with fibrinolytic-treated STEMI.
Le texte complet de cet article est disponible en PDF.Plan
Vol 109 - N° 3
P. 320-326 - février 2012 Retour au numéro
Article précédent
- Implications of ST-Segment Elevation in Leads V5 and V6 in Patients With Reperfused Inferior Wall Acute Myocardial Infarction
- Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Noriaki Iwahashi, Satoshi Morita, Mitsuaki Endo, Nobuhiki Maejima, Masaomi Gouhara, Zenkou Nagashima, Satoshi Umemura, Kazuo Kimura
- Predictors of Depressed Left Ventricular Function in Patients Presenting With ST-Elevation Myocardial Infarction
- Prashant D. Bhave, Kurt S. Hoffmayer, Ehrin J. Armstrong, Sonia Garg, Ateet Patel, John S. MacGregor, John C. Stein, Scott Kinlay, Peter Ganz, James M. McCabe
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?